AstraZeneca Coronavirus Vaccine Clinical Trials Resume In U.K. After Pause Over Safety Concerns

AstraZeneca coronavirus vaccine clinical trials resume in U.K. after pause over safety concerns
PUBLISHED SAT, SEP 12 20209:38 AM EDTUPDATED 3 HOURS AGO
[link to www.cnbc.com (secure)]

The United Kingdom’s Medicines Health Regulatory Authority [said] that it was safe to resume clinical trials after a brief pause.

AstraZeneca paused trials earlier this week due to a potentially unexplained illness.

CEO Pascal Soriot said during a private conference call that the illness occurred in a woman in the U.K. who displayed neurological symptoms consistent with a spinal inflammatory disorder called transverse myelitis.

Illnesses often occur by chance in large trials but are investigated out of an abundance of caution.